Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels

Transfusion

Volumn 49, Issue 2, 2009, Pages 301-310

  Assal, Azzedine ^a   Barlet, Valérie ^b   Deschaseaux, Marie ^b   Dupont, Isabelle ^b   Gallian, Pierre ^b   Guitton, Cathy ^b   Morel, P ^b   Van Drimmelen, Harry ^b   David, Bernard ^b   Lelie, Nico ^b   De Micco, Philippe ^b  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOASSAY; MEDICAL INSTRUMENTATION; NUCLEIC ACID AMPLIFICATION; SEROCONVERSION; VIREMIA;

DNA, VIRAL; HEPACIVIRUS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HIV; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TIME FACTORS; VIREMIA;

EID: 58849143103     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01966.x     Document Type: Article

References (25)

1. Assal A, Coste J, Barlet V, Laperche S, Cornillot C, Smilovici W, Pillonel J, Andreu G. Application of molecular biology to blood transfusion safety: the nucleic acid testing. Transfus Clin Biol 2003 10 : 217 26.
2. Coste J, Cornillot C. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology. International forum. Vox Sang 2002 82 : 87 111.
3. Najiouallah F, Barlet V, Renaudier P, Guitton C, Crova P, Guérin JC, Peyramond D, Trabaud MA, Coudurier N, Tardy JC, André P. Failure and success of HIV tests for the prevention of HIV 1 transmission by blood and tissue donatons. J Med Virol 2004 73 : 347 9.
4. Pillonel J, Laperche S, Saura C, Desenclos JC, Courouce AM. Trends in residual risk of transfusion-transmitted viral infections in France between 1992-2000. Transfusion 2002 42 : 980 8.
5. Pillonel J, Laperche S. Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT). Euro Surveill 2005 10 : 5 8.
6. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005 45 : 254 64.
7. Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, Bernard D., De Micco P. Comparison of the analytical and operational performance of two automated nucleic acid test blood screening systems: Procleix Tigris and cobas s 201. Transfusion DOI: 10.1111/j.1537-2995.2008.01966.x.
8. Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW, Peddada L, Smith R, Schreiber GB, Epstein JS, Nemo GJ, Busch MP. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003 43 : 788 98.
9. Glynn SA, Wright DJ, Kleinman SH, Hirschkorn D, Tu Y, Heldebrant C, Smith R, Giachetti C, Gallarda J, Busch MP. Dynamics of viremia in early hepatitis C virus infection. Transfusion 2005 45 : 994 1002.
10. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch MP. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003 17 : 1871 9.
11. Ly TD, Ebel A, Faucher V, Fihman V, Laperche S. Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays? J Virol Methods 2007 143 : 86 94.
12. Weber B, Gurtler L, Thorstensson R, Michl U, Mühlbacher A, Bürgisser P, Villaescusa R, Eiras A, Gabriel C, Stekel H, Tanprasert S, Oota S, Silvestre MJ, Marques C, Ladeira M, Rabenau H, Berger A, Schmitt U, Melchior W. Multi-center evaluation of a new automated fourth generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity. J Clin Microbiol 2002 40 : 1938 46.
13. Busch M, Glynn SA, Wright DJ, Hirschkorn D, Laycock ME, McAuley J, Tu Y, Giachetti C, Gallarda J, Heitman J, Kleinman SH. Realtive sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection. Transfusion 2005 45 : 1853 63.
14. Koppelman M, Assal A, Chudy M, Torres P, de Villaescusa RG, Reesink HW, Lelie PN, Cuypers HT. Multi-center performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations. Transfusion 2005 45 : 1258 66.
15. Gerlich WH, Glebe D, Schüttler CG. Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. J Viral Hepatitis 2007 Suppl 1 : 16 21.
16. Minegishi K, Yoshikawa A, Kishimoto S, Yugi H, Yokoya N, Sakurada M, Kiyokawa H, Nishioka K. Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening. Vox Sang 2003 84 : 287 91.
17. Kleinman SH, Busch MP. Assessing the impact of HBV NAT on window period reduction and residual risk. J Clin Virol 2006 36 Suppl 1 : Suppl 23 9.
18. Vermeulen M, Busch MP, Lelie N, Sykes W, Swanevelder R, Le Roux M, Gaggia L, Reddy R. Observed yield and projected residual risk using HIV individual donation (ID)-NAT, minipool (MP)-NAT or HIV p24 antigen (p24 Ag) screening in South Africa. ISBT abstract Macao, 4C-S28-03. Vox Sang 2008 95 Suppl 1 : 55 6.
19. Zaaijer HL, Exel-Oehlers P, Kraaijeveld T, Altena E, Lelie PN. Early detection of antibodies to HIV 1 by third-generation assays. Lancet 1992 340 : 770 2.
20. Ling AE, Robbins KE, Brown TM, Dunmire V, Thoe SY, Wong SY, Leo YS, Teo D, Gallarda J, Phelps B, Chamberland ME, Busch MP, Folks TM, Kalish ML. Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period. JAMA 2000 284 : 210 4.
21. Delwart EL, Kalmin ND, Jones TS. First report of a human immunodeficiency virus transmission via an RNA screened negative blood donation. Vox Sang 2004 86 : 171 7.
22. Fereira MD, Nel TJ. Differential transmission of human immunodeficiency virus (HIV) via blood components from an HIV infected blood donor. Transfusion 2006 46 : 156 7.
23. Schüttler CG, Caspari G, Jursch CA, Willems WR, Gerlich WH, Schaefer S. Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet 2000 355 : 41 2.
24. Grabarczyk P, Gronowska A, Brojer E, Letowska M, Radziwon P. Sequence analysis confirmation of trnasfusion transmitted hepatitis C by red blood cells that tested negative by minipool hepatits C virus nucleic acid testing. Transfusion 47 : 1102 4.
25. Kretzschmar E, Chudy M, Nübling CM, Ross RS, Kruse F, Trobisch H. First case of hepatitis C transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assays. Vox Sang 2007 92 : 297 301.